Clinical Trial Update: Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating pharmacodynamic analyses of metabolic agents following brain radiation has been withdrawn. The sponsor is Mayo Clinic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Central Nervous System Neoplasm

Snippet

Sponsor: Mayo Clinic | Conditions: Malignant Central Nervous System Neoplasm | Phase 1 | Status: WITHDRAWN